Skip to content

Clinical trials

Phase 3 Body Weight Changes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Body Weight Changes Phase: Phase 3 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20071
20101
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology1
Eli Lilly and Company1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Prism Health North Texas1
Solvay Pharmaceuticals1
University of Illinois at Chicago1
University of South Florida1
Wake Forest University Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Body Weight Changes8
Obesity3
Cachexia2
Schizophrenia2
Acquired Immunodeficiency Syndrome1
Anorexia1
Astrocytoma1
Bone Neoplasms1
Breast Neoplasms1
Chondrosarcoma1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.